Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2008
11/05/2008EP1987833A1 Use of pharmacological compounds for the prevention or the treatment of acute tolerance to morphinics.
11/05/2008EP1987832A1 Sustained-release tablet composition of pramipexole
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987811A1 Skin-whitening cosmetic
11/05/2008EP1986663A2 Adenosine monophosphate for inducing torpor in a subject
11/05/2008EP1986612A2 Stabilized compositions of proteins having a free thiol moiety
11/05/2008EP1768665B1 Peptidomimetic inhibitors of hiv protease
11/05/2008EP1761515B1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives
11/05/2008EP1740201B1 Pharmaceutical compositions comprising interferon-tau
11/05/2008EP1526140B1 Potassium-dependent sodium-calcium exchanger
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1448215B1 Use of laminarin in the treatment of cancer
11/05/2008EP1393739B1 Adiponection for liver regeneration
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1372671B1 Methylation modulating agents for intraductal treatment of breast cancer
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008EP1003532B2 Lactobacilli to increase absorption of minerals by intestinal cells
11/05/2008EP0927196B1 Polymers containing polysaccharides such as alginates or modified alginates
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300014A Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
11/05/2008CN101300000A Equol level regulator
11/05/2008CN101299991A Fibroblast activator, method for activation of fibroblast, collagen synthesis promoter, method for promotion of collagen synthesis, skin aging-preventing agent, and method for prevention of aging of t
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN101297939A Chinese medicine preparation for raising weight of broiler chickens and preparation thereof
11/05/2008CN101297885A Chinese medicine preparation for treating heat stress of cow in summer and preparation method thereof
11/05/2008CN101297860A Chinese medicinal composition for preventing and controlling heat stress and heatstroke of birds
11/05/2008CN100430414C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C)
11/05/2008CN100430403C 3-aryl-5,6-substituted thienopyrimidine-4-carbonyl-2-mercaptoacetonitrile, and its synthesizing method and use
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430380C Pyridylacetylenes for use as radiotracers and imaging agents
11/05/2008CN100430089C The use of melagatran for the manufacture of a medicament for the treatment of type I diabetes mellitus
11/05/2008CN100430073C Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug
11/05/2008CN100430071C Medicine for lowering blood sugar and treating women menopausal syndrome and preparation method thereof
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430063C Combination therapy wherein a serotonin reuptake inhibitor is used
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/05/2008CN100430046C Composition and method for treating age-related disorders
11/05/2008CN100429996C Antifatigue health product improving human body immunity function effectively and preparing method thereof
11/04/2008US7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446120 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445776 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008CA2457361C Opioid agonist formulations with releasable and sequestered antagonist
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2332814C Combination therapy for treatment of refractory depression
10/2008
10/30/2008WO2008130370A1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008129951A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
10/30/2008WO2008129874A1 Method of targeting tumor cell and use of the same
10/30/2008WO2008129720A1 Moisturizing agent, antiaging agent, whitening agent, antioxidant, slimming agent, treatment agent, alginase activity promoter and external agent for the skin
10/30/2008WO2008129308A2 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
10/30/2008WO2008128704A1 Use of hydroxytyrosol as anti-aging agent
10/30/2008WO2008128415A1 A medicine for improving quality of blood, preparation method and uses thereof
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269487 6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline; prevent, treat tumours which are sensitive to inhibition of erbB receptor tyrosine kinases
10/30/2008US20080269351 Alkylated hydroxyaromatic compound substantially free of endocrine disruptive chemicals and method of making the same
10/30/2008US20080269350 St104p, an anti-angiogenic agent
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269304 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
10/30/2008US20080269285 Use of these iminoxylitol compounds for treatment of Gaucher's disease
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269238 Thiazolopyrimidine Derivative
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269203 Compositions and methods relating to novel compounds and targets thereof
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269178 Antiinflammatory agents; heating glucocorticoid with water and surfactant
10/30/2008US20080269176 New Salts
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/30/2008US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269129 Polypeptide and dna thereof useful as a neovascular marker
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269106 Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268484 Using thrombin-antithrombin III complex as tool in identifying modulators of glypican-3 expression; treating arteriosclerosis
10/30/2008US20080268073 derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, Rutaceae, Laminariaceae, Myrtaceae and Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1564